Referral of intravenous drug users for antiviral treatment: effectiveness of hepatitis C case-finding programmes
Jazyk angličtina Země Česko Médium print
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
23285525
DOI
10.21101/cejph.a3747
Knihovny.cz E-zdroje
- MeSH
- antivirové látky terapeutické užití MeSH
- hepatitida C diagnóza epidemiologie terapie MeSH
- intravenózní abúzus drog epidemiologie terapie MeSH
- konziliární vyšetření a konzultace statistika a číselné údaje MeSH
- lidé MeSH
- pacientův souhlas se zdravotní péčí statistika a číselné údaje MeSH
- plošný screening statistika a číselné údaje MeSH
- zdravé chování MeSH
- zdravotnické služby statistika a číselné údaje MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- Maďarsko epidemiologie MeSH
- Názvy látek
- antivirové látky MeSH
BACKGROUND: Hepatitis C infection (HCI) case-finding programmes aim to identify infected persons in a well-defined population. This study assessed the effectiveness of three HCI case-finding programmes for intravenous drug users by examining the rate of their referral to antiviral treatment. METHODS: The Hepatology Outpatient Clinic of Szent László Hospital examines and treats all intravenous drug users who are found positive in HCI case-finding programmes in Budapest. The medical records of patients who visited the Hepatology Outpatient Clinic of Szent László Hospital between 1 January 2006 and 31 December 2008 were screened and records indicating a history of drug abuse were selected. These records were matched against the databases of the hepatitis case-finding programmes and the records that appeared in both datasets were analyzed. RESULTS: Of the 234 intravenous drug users identified as hepatitis C virus positive in the Budapest case-finding programmes, only 21 attended the Hepatology Outpatient Clinic of Szent László Hospital and only two started antiviral treatment, but their hepatitis C virus positive status had already been known at the time of screening. CONCLUSION: In this study, not a single patient with drug abuse whose hepatitis C virus positive status was identified in one of the HCI case-finding programmes was referred for antiviral treatment.
Citace poskytuje Crossref.org